RT @LucasLealMontes: Enlace 20: https://t.co/db9L0psxb7 Enlace 21: https://t.co/bfuQoUPs4Z https://t.co/XQqptgu31O
RT @LucasLealMontes: Enlace 20: https://t.co/db9L0psxb7 Enlace 21: https://t.co/bfuQoUPs4Z https://t.co/XQqptgu31O
Enlace 20: https://t.co/db9L0psxb7 Enlace 21: https://t.co/bfuQoUPs4Z https://t.co/XQqptgu31O
@SwaledaleMutton @Maccspider @zoeharcombe There's plenty of doubt in this one https://t.co/I36eY4URk1
RT @obgyntommy: ② がん患者さんにおけるワクチン効果に関するデータは限られています。 -米国におけるmRNAワクチン(モデルナ社もしくはファイザー/ビオンテック社製)を2回接種した患者のワクチン効果は固形腫瘍で79%、血液腫瘍で74%という報告があります。 ht…
② がん患者さんにおけるワクチン効果に関するデータは限られています。 -米国におけるmRNAワクチン(モデルナ社もしくはファイザー/ビオンテック社製)を2回接種した患者のワクチン効果は固形腫瘍で79%、血液腫瘍で74%という報告があります。 https://t.co/wbsrwNetGl
@with_Kittens2 LOL, not sure we are talking about he same thing. When I first asked about the slide u linked to the following but the following is only up to Sept. 2021: https://t.co/Ru9k4QUmWy
@IsabelAphrael @sarit_yael So it’s from here: https://t.co/YjLPhaJ7jO I looked quickly at methodology and I think it’s relative to covid + cases, so I actually think some of these explanations wouldn’t apply, since they just predict higher cases eg from ki
@Lisa2Oz A very recent study published by the CDC reported that a majority (53%) of patients who were hospitalized with Covid-19-like illnesses were already fully vaccinated with two-dose RNA shots. https://t.co/q7biUtoo1l
@jchiossonek Algunos estudios que soportan, no que justifican, mi crítica en cuanto a la efectividad del tratamiento experimental con ARNm: https://t.co/xbQgg5CR79 https://t.co/JVzX4b4tyV https://t.co/KVuGmu5nT3 https://t.co/Dhn4d0Gtho https://t.co/OL
Reference from @CDCMMWR on effectiveness of 2-dose vaccination in immunocompromised adults https://t.co/km0OT3n0IY
RT @carpe_diem0820: COVID-19ワクチンに対する抗体反応は、固形臓器移植者、抗CD20モノクローナル抗体の接種者、モデルナ以外のワクチンの接種者で低かった Prospective evaluation of COVID-19 vaccine respo…
RT @carpe_diem0820: COVID-19ワクチンに対する抗体反応は、固形臓器移植者、抗CD20モノクローナル抗体の接種者、モデルナ以外のワクチンの接種者で低かった Prospective evaluation of COVID-19 vaccine respo…
COVID-19ワクチンに対する抗体反応は、固形臓器移植者、抗CD20モノクローナル抗体の接種者、モデルナ以外のワクチンの接種者で低かった Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study https://t.co/I7yLbE8rm3 https://t.co/9FuExwymsV
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/85fmPDvEoO via @CDCgov
@segfaultvicta I mean 77% is still *pretty dang great*, and it's precisely the broad blanket statements that are the issue: https://t.co/e90a8nlOOS
@SteveKornacki "my immunocompromised dad will still absolutely die if anyone in my house gets it" Likely not as bad as you think. Perhaps not enough for society to be turned upside down to offer little additional protection for your dad. https://t.co/CQ
@fitterhappierAJ @gianlucac1 https://t.co/Wu6XzOvroy Hi DR FJ, it is known that a low percentage of patients with solid organ transplant, bone marrow and hematologic cancer have an extremely poor humoral response. What would be protecting these patients f
@ashleydixon @SteveDelfino @AShihipar if 3-4% of the population were incapable of *any* robust immune response then we wouldn't see these VE numbers https://t.co/tuLzLnRsbV
@ashleydixon @SteveDelfino @AShihipar You're also wrong to make a blanket statement about "immunocompromised" like that--some people on immunosuppressants or with other conditions can still generate some antibodies mRNA VE against severe illness around 77
@SansMarcuello @helixx85 Aquest estudi situa la diferència en l'eficàcia de les vacunes d'ARNm entre persones immunocompetents i persones immunodeficients en només 13 punts percentuals (90% contra 77%) que no vol dir “pràcticament inexistent” ni molt menys
@DrDanSchumacher @karenvaites My understanding from my own personal virologist, @samuellmurphy1 is that even in immunocompromised individuals, the vaccine still has 77% effectiveness. Is that your understanding as well? Do you have additional info about k
@WendyLacey6 @dichondrablue @DrKate_Miller There is generally some research (not a lot admittedly) that shows vaccination confers benefit to people with immunosuppression - but not perhaps to same extent with normal immune system https://t.co/BsSyN8Zprw
@FeilichAbby This study says 77% which is better than we were told https://t.co/3JqsiHksgF https://t.co/T4CT9kNJdt
RT @HeadlessHenArts: @g8trphin @Lindsvy @justxhenry @Tendurag Also CDC source that's a bit of a drag to read... Basically immunocompromised…
RT @Ferhatarslandr: Amerikan verileri ile konuşalım. Diyelim ki bağışıklık sisteminiz zayıf ve aşı oldunuz korunuyor musunuz? Hayır diyorl…
@Songbir40253612 @freethought202 Ok ... new data https://t.co/1IfBo3KZLR
@Racing_Away @freethought202 Wait no longer .. https://t.co/1IfBo3KZLR Table 2
@TypicalTrumpie @GanjaGrrl @TinaMGLong @CawthornforNC https://t.co/BHRh7dtn4g https://t.co/f2De4LBN5z https://t.co/PgbGmIiRlq https://t.co/5fxSTV7sal I could keep going. This is reflected in global data as well. Would you like me to provide scientific
COVID-19. Las vacunas son menos efectivas para proteger contra el COVID-19 severo en adultos inmunodeprimidos. https://t.co/lVpwOQfNac https://t.co/TdMYL5eqDm
@max23926445 @LeeZee_Bee @Dikgoba https://t.co/A3oasXOnpC How about this stupidarticle? Have you even read that latest report?
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/urcUn90iFx via @CDCgov
Wow. The 2-Dose MRNA vaccines are 77% effective against hospitalization for *immunocompromised* folks. Much greater protection than I would have assumed based on the discourse here (Study is a couple weeks old, but just coming across it now) https://t.
@endocine @business please educate yourself... https://t.co/lUnPoR2ORd https://t.co/cEYVQ5wQVk
RT @IDFCommunity: A new report from @CDCgov discusses the effectiveness of the #COVID19 vaccine among #immunocompromised adults: https://t…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @Ferhatarslandr: Amerikan verileri ile konuşalım. Diyelim ki bağışıklık sisteminiz zayıf ve aşı oldunuz korunuyor musunuz? Hayır diyorl…
@mattbc Also, immunocompromised should get a booster shot 6 months after the full 3rd dose per CDC guidelines https://t.co/y9v6gOdKOQ
RT @Ferhatarslandr: Amerikan verileri ile konuşalım. Diyelim ki bağışıklık sisteminiz zayıf ve aşı oldunuz korunuyor musunuz? Hayır diyorl…
RT @Ferhatarslandr: Amerikan verileri ile konuşalım. Diyelim ki bağışıklık sisteminiz zayıf ve aşı oldunuz korunuyor musunuz? Hayır diyorl…
RT @Ferhatarslandr: Amerikan verileri ile konuşalım. Diyelim ki bağışıklık sisteminiz zayıf ve aşı oldunuz korunuyor musunuz? Hayır diyorl…
RT @EricTopol: Immuncompromised comprise ~3% of the US population. A new @CDCMMWR report shows that mRNA vaccines are holding up fairly wel…
RT @EricTopol: Immuncompromised comprise ~3% of the US population. A new @CDCMMWR report shows that mRNA vaccines are holding up fairly wel…
CDC report on immuno-competent vs immuno-compromised with regards to vaccine effectiveness. TLDR: If your not immuno-compromised, you dont need them. https://t.co/7RiXUs9qvz
A new CDC report finds that although COVID-19 vaccines continue to help prevent hospitalization, some immunocompromised adults have lower protection. Immunocompromised people should get all recommended COVID-19 vaccine doses, including primary and booster
RT @mahesh_shenai: 1b/ https://t.co/2eIHLmyiXa SPOILER: The sister paper (“IC”) studied the SAME hosp. data in the SAME time period for di…
1b/ https://t.co/2eIHLmyiXa SPOILER: The sister paper (“IC”) studied the SAME hosp. data in the SAME time period for different ??s, but found a general infxn rate in unvaxed of 3-5x vs. either previous infection (PI) or vaccination (FV). In other words, s
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines -https://t.co/fjY53HWENw via @CDCgov
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines https://t.co/qsGLkF1C2q via @CDCgov
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @TresaMcNealMD: https://t.co/rcG0LxPOjm This adds to our knowledge of covid vaccination and the immunocompromised popoulation. Congrats…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
https://t.co/rcG0LxPOjm This adds to our knowledge of covid vaccination and the immunocompromised popoulation. Congrats @manjugaglani for your involvement!
Tutkimus korostaa immuuniheikkojen rokotuksia, ja sitä ettei kaksi annosta (mRNA rokotetta) riitä. Suositellaan perusannokseksi kolmea ja sen lisäksi tehostetta, joka olisi neljäs. 2/⛓ https://t.co/uw82EOGCFq
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
RT @influenzer3: Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunoc…
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 https://t.co/Ap4sNDU7Ir
Immunsupprimierte Patienten gibt es leider ganz schön oft. Deshalb. Let‘s booster! #COVID19 #SARSCoV2 #corona #coronavirus #impfen #ImpfenSchuetzt #Drittimpfung #Booster #BoosterShot https://t.co/2huWqHnpZQ
RT @WeThePeeple9: Sawse: https://t.co/9DgLht99C6
Sawse: https://t.co/9DgLht99C6
RT @EricTopol: Immuncompromised comprise ~3% of the US population. A new @CDCMMWR report shows that mRNA vaccines are holding up fairly wel…
@b6m @oksnocowa @ChanceTyColeman You’re right, I’m not a scientist. But does it take a scientist or a PhD to see that data is seems to be so skewed and often questionable? In this study a fever, vomiting or diarrhea is consider as a covid positive. That’s
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @CDCMMWR: Immunocompromised people should get all recommended COVID-19 vaccine doses, including primary and booster doses, consistent wi…
RT @CDCMMWR: Immunocompromised people should get all recommended COVID-19 vaccine doses, including primary and booster doses, consistent wi…
RT @CDCMMWR: Immunocompromised people should get all recommended COVID-19 vaccine doses, including primary and booster doses, consistent wi…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
Effectiveness of mRNA vaccination against laboratory-confirmed COVID-19–associated hospitalization was lower (77%) among immunocompromised adults than among immunocompetent adults (90%). https://t.co/9nLmBjypHy
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. https://t.co/rvfT4BdtRe
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @carpe_diem0820: mRNAワクチンのCOVID-19関連入院予防効果は、免疫不全者で健常者より低く(77 vs 90%)、詳細内容により効果が大きく異なる Effectiveness of 2-Dose Vaccination with mRNA COV…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
ステロイドを長期服用の僕としては 安心のためにも3回目は早く打ちたいなって思う
RT @SukunaBikona7: アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果9…
アメリカ、免疫抑制者のCOVID-19 mRNAワクチンの有効性。 2021/1-9、免疫抑制者2万人と非免疫抑制者6.9万人を比較。 免疫抑制者でのCOVID-19 mRNAワクチンの入院予防効果は77%であり、非抑制者での入院予防効果90%よりも低かった。 https://t.co/Ayicn6fEpw
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021 https://t.co/ucvvAYrfYn
RT @Ferhatarslandr: Amerikan verileri ile konuşalım. Diyelim ki bağışıklık sisteminiz zayıf ve aşı oldunuz korunuyor musunuz? Hayır diyorl…